Development of Angiogenesis Inhibition as Therapy for Prostate Cancer
December 2nd 2000Angiogenesis is essential to prostate cancer progression. The first study of antiangiogenic therapy in patients with locally advanced prostate cancer at The University of Texas M. D. Anderson Cancer Center showed that